Tobias Haas

1.8k total citations
24 papers, 1.1k citations indexed

About

Tobias Haas is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Tobias Haas has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 8 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Tobias Haas's work include interferon and immune responses (9 papers), Immune Cell Function and Interaction (9 papers) and Immune Response and Inflammation (8 papers). Tobias Haas is often cited by papers focused on interferon and immune responses (9 papers), Immune Cell Function and Interaction (9 papers) and Immune Response and Inflammation (8 papers). Tobias Haas collaborates with scholars based in Germany, United States and Belgium. Tobias Haas's co-authors include Hermann Wagner, Frank Schmitz, Antje Heit, Jochen Metzger, Hendrik Poeck, Thomas Müller, Eicke Latz, Simon Heidegger, Anne Krug and Jörg Mages and has published in prestigious journals such as Blood, Immunity and The Journal of Immunology.

In The Last Decade

Tobias Haas

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tobias Haas Germany 14 802 388 153 137 85 24 1.1k
Isabelle Frémaux France 14 1.0k 1.3× 304 0.8× 163 1.1× 195 1.4× 70 0.8× 21 1.4k
Hansjörg Schild Germany 13 805 1.0× 356 0.9× 179 1.2× 110 0.8× 36 0.4× 13 1.0k
Unni Nonstad Norway 11 492 0.6× 282 0.7× 92 0.6× 86 0.6× 106 1.2× 13 818
Steve J. Webster United Kingdom 11 514 0.6× 416 1.1× 223 1.5× 74 0.5× 90 1.1× 14 936
Sandra Balkow Germany 21 927 1.2× 250 0.6× 163 1.1× 189 1.4× 40 0.5× 29 1.3k
Afsaneh Soruri Germany 20 753 0.9× 355 0.9× 195 1.3× 129 0.9× 49 0.6× 28 1.3k
Ana‐Maria Dragoi United States 13 422 0.5× 392 1.0× 92 0.6× 91 0.7× 70 0.8× 25 934
Yvonne K. Mburu United States 11 563 0.7× 175 0.5× 145 0.9× 107 0.8× 56 0.7× 13 781
Hiroaki Azukizawa Japan 18 1.1k 1.3× 216 0.6× 140 0.9× 110 0.8× 29 0.3× 43 1.7k
Dominique Velin Switzerland 20 734 0.9× 338 0.9× 179 1.2× 161 1.2× 85 1.0× 50 1.3k

Countries citing papers authored by Tobias Haas

Since Specialization
Citations

This map shows the geographic impact of Tobias Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Haas more than expected).

Fields of papers citing papers by Tobias Haas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Haas. The network helps show where Tobias Haas may publish in the future.

Co-authorship network of co-authors of Tobias Haas

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Haas. A scholar is included among the top collaborators of Tobias Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Haas. Tobias Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heidegger, Simon, Alexander Wintges, Sarah Bek, et al.. (2019). RIG-I activation is critical for responsiveness to checkpoint blockade. Science Immunology. 4(39). 96 indexed citations
2.
Fischer, Julius, Michael Bscheider, Erik Thiele Orberg, et al.. (2019). Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells. Scientific Reports. 9(1). 14955–14955. 10 indexed citations
3.
Heidegger, Simon, Michael Bscheider, Tatiana Nedelko, et al.. (2019). RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade. EBioMedicine. 41. 146–155. 36 indexed citations
4.
Fischer, Julius, Chia-Ching Lin, Simon Heidegger, et al.. (2018). Regeneration After Radiation- and Immune-Mediated Tissue Injury Is Not Enhanced by Type III Interferon Signaling. International Journal of Radiation Oncology*Biology*Physics. 103(4). 970–976. 4 indexed citations
5.
Fischer, Julius, Vera Otten, Christoph Drees, et al.. (2017). A20 Restrains Thymic Regulatory T Cell Development. The Journal of Immunology. 199(7). 2356–2365. 28 indexed citations
6.
Fischer, Julius, Vera Otten, Katja Steiger, et al.. (2017). A20 deletion in T cells modulates acute graft‐versus‐host disease in mice. European Journal of Immunology. 47(11). 1982–1988. 7 indexed citations
7.
Parker, Rebecca E., Franka Kálmán, Tobias Haas, et al.. (2017). Cell culture media supplemented with raffinose reproducibly enhances high mannose glycan formation. Journal of Biotechnology. 252. 32–42. 19 indexed citations
8.
Fischer, Julius, Alexander Wintges, Tobias Haas, & Hendrik Poeck. (2017). Assessment of mucosal integrity by quantifying neutrophil granulocyte influx in murine models of acute intestinal injury. Cellular Immunology. 316. 70–76. 17 indexed citations
9.
Fischer, Julius, Christian Stemberger, Stefan Dreher, et al.. (2017). Minimally manipulated murine regulatory T cells purified by reversible Fab Multimers are potent suppressors for adoptive T‐cell therapy. European Journal of Immunology. 47(12). 2153–2162. 9 indexed citations
10.
Heidegger, Simon, Michael Bscheider, Alexander Wintges, et al.. (2015). The RIG-I Agonist 3pRNA Synergizes with Checkpoint Blockade in Cancer Immunotherapy. Blood. 126(23). 3436–3436. 1 indexed citations
11.
Bek, Sarah, et al.. (2014). P57. Activation of RIG-I induces immunogenic cell death. Journal for ImmunoTherapy of Cancer. 2(S2). 1 indexed citations
12.
Fischer, Julius, Caroline A. Lindemans, Chia-Ching Lin, et al.. (2014). The Role of the Cytoplasmic RNA Sensor Retinoic Acid Inducible Gene- I (RIG-I) in Allogeneic Stem Cell Transplantation. Blood. 124(21). 3827–3827. 1 indexed citations
13.
Heidegger, Simon, Marcel R.M. van den Brink, Tobias Haas, & Hendrik Poeck. (2014). The Role of Pattern-Recognition Receptors in Graft-Versus-Host Disease and Graft-Versus-Leukemia after Allogeneic Stem Cell Transplantation. Frontiers in Immunology. 5. 337–337. 52 indexed citations
14.
15.
Schmitz, Frank, Antje Heit, Stefan Dreher, et al.. (2008). Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. European Journal of Immunology. 38(11). 2981–2992. 177 indexed citations
16.
Haas, Tobias, Jochen Metzger, Frank Schmitz, et al.. (2008). The DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation. Immunity. 28(3). 315–323. 227 indexed citations
17.
Heit, Antje, Frank Schmitz, Tobias Haas, Dirk H. Busch, & Hermann Wagner. (2007). Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity. European Journal of Immunology. 37(8). 2063–2074. 102 indexed citations
18.
Schmitz, Frank, Antje Heit, Anne Krug, et al.. (2007). Interferon‐regulatory‐factor 1 controls Toll‐like receptor 9‐mediated IFN‐β production in myeloid dendritic cells. European Journal of Immunology. 37(2). 315–327. 115 indexed citations
19.
Koschny, Ronald, Jaromir Sykora, Henning Walczak, et al.. (2007). Bortezomib-Mediated Up-Regulation of TRAIL-R1 and TRAIL-R2 Is Not Necessary for but Contributes to Sensitization of Primary Human Glioma Cells to TRAIL. Clinical Cancer Research. 13(21). 6541–6542. 5 indexed citations
20.
Yasuda, Kei, Mark Rutz, Jochen Metzger, et al.. (2006). CpG motif‐independent activation of TLR9 upon endosomal translocation of “natural” phosphodiester DNA. European Journal of Immunology. 36(2). 431–436. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Frémaux Breakdown of academic impact, for papers by Hansjörg Schild Breakdown of academic impact, for papers by Unni Nonstad Breakdown of academic impact, for papers by Steve J. Webster Breakdown of academic impact, for papers by Sandra Balkow Breakdown of academic impact, for papers by Afsaneh Soruri Breakdown of academic impact, for papers by Ana‐Maria Dragoi Breakdown of academic impact, for papers by Yvonne K. Mburu Breakdown of academic impact, for papers by Hiroaki Azukizawa Breakdown of academic impact, for papers by Dominique Velin
Rankless by CCL
2026